| Literature DB >> 35148797 |
Je Sung You1, Yoo Seok Park1, Sung Phil Chung1, Hye Sun Lee2, Soyoung Jeon2, Won Young Kim3, Tae Gun Shin4, You Hwan Jo5, Gu Hyun Kang6, Sung Hyuk Choi7, Gil Joon Suh8, Byuk Sung Ko9, Kap Su Han10, Jong Hwan Shin11, Taeyoung Kong12.
Abstract
BACKGROUND: Nighttime hospital admission is often associated with increased mortality risk in various diseases. This study investigated compliance rates with the Surviving Sepsis Campaign (SSC) 3-h bundle for daytime and nighttime emergency department (ED) admissions and the clinical impact of compliance on mortality in patients with septic shock.Entities:
Keywords: Off-hour effect; Sepsis; Septic shock; Surviving Sepsis Campaign
Mesh:
Year: 2022 PMID: 35148797 PMCID: PMC8832860 DOI: 10.1186/s13054-022-03899-0
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Flow diagram of patient inclusion and exclusion. KoSS Korean Shock Society, MAP mean arterial pressure
Comparison of demographic and clinical characteristics for daytime versus nighttime admissions of all patients admitted to the emergency department and those with septic shock
| Variables | Total | Day | Night | |
|---|---|---|---|---|
| Age (years) | 67.9 ± 13.6 | 68.1 ± 13.4 | 67.7 ± 14.0 | 0.595 |
| Male sex [ | 1196 (58.4) | 684 (58.0) | 512 (58.9) | 0.666 |
| Severity score | ||||
| SOFA score (points) | 6.07 ± 3.16 | 6.11 ± 3.15 | 6.02 ± 3.17 | 0.567 |
| APACHE II score (points) | 20.24 ± 9.11 | 20.31 ± 9.15 | 20.15 ± 9.07 | 0.703 |
| Initial vital sign | ||||
| Systolic blood pressure (mmHg) | 89.2 ± 23.9 | 88.9 ± 22.8 | 89.6 ± 25.4 | 0.567 |
| Diastolic blood pressure (mmHg) | 53.8 ± 16.2 | 53.5 ± 15.3 | 54.1 ± 17.3 | 0.411 |
| Body temperature (°C) | 37.7 ± 1.3 | 37.6 ± 1.3 | 37.7 ± 1.4 | 0.118 |
| Past medical history [ | ||||
| Hypertension | 846 (41.3) | 490 (41.5) | 356 (41.0) | 0.799 |
| Diabetes mellitus | 627 (30.6) | 348 (29.5) | 279 (32.1) | 0.204 |
| Cardiovascular disease | 275 (13.4) | 166 (14.1) | 109 (12.5) | 0.317 |
| Cerebrovascular disease | 250 (12.2) | 148 (12.5) | 102 (11.7) | 0.582 |
| Chronic lung disease | 164 (8.0) | 103 (8.7) | 61 (7.0) | 0.159 |
| Hematologic malignancy | 134 (6.5) | 78 (6.6) | 56 (6.4) | 0.881 |
| Metastatic cancer | 452 (22.1) | 245 (20.8) | 207 (23.8) | 0.099 |
| Chronic kidney disease | 151 (7.4) | 86 (7.3) | 65 (7.5) | 0.869 |
| Chronic liver disease | 242 (11.8) | 128 (10.9) | 114 (13.1) | 0.115 |
| Transplantation | 39 (1.9) | 22 (1.9) | 17 (2.0) | 0.881 |
| AIDS | 5 (0.2) | 3 (0.3) | 2 (0.2) | > 0.999 |
| Source of infection [ | ||||
| GI tract | 360 (17.6) | 184 (15.6) | 176 (20.3) | 0.006* |
| Hepatobiliary or pancreas | 239 (11.7) | 137 (11.6) | 102 (11.7) | 0.929 |
| Respiratory | 53 (2.6) | 31 (2.6) | 22 (2.5) | 0.893 |
| Soft tissue/bone/joint | 123 (6.0) | 75 (6.4) | 48 (5.5) | 0.433 |
| Urinary | 1241 (60.6) | 684 (58.0) | 557 (64.1) | 0.005* |
| Mixed | 105 (5.1) | 65 (5.5) | 40 (4.6) | 0.358 |
| Unknown | 386 (18.8) | 221 (18.7) | 165 (19.0) | 0.882 |
| Laboratory data | ||||
| White blood cell count (103/μL) | 13.2 ± 16.7 | 13.8 ± 18.6 | 12.4 ± 13.7 | 0.047* |
| C-reactive protein (mg/L) | 14.42 ± 12.68 | 15.21 ± 13.51 | 13.35 ± 11.37 | < 0.001* |
| Lactate (mmol/L) | 4.37 ± 3.31 | 4.22 ± 3.21 | 4.58 ± 3.42 | 0.017* |
| Lactate clearance (%) | 10.0 ± 58.8 | 9.6 ± 62.3 | 10.7 ± 54.1 | 0.743 |
| Duration of lactate measurement (H) | 2.6 ± 1.5 | 2.7 ± 1.5 | 2.4 ± 1.5 | 0.010* |
| Volume of patients | ||||
| Patients/doctor ratio | 1.19 ± 0.44 | 1.25 ± 0.33 | 1.10 ± 0.54 | < 0.001* |
| Patients/nurse ratio | 0.86 ± 0.32 | 0.95 ± 0.28 | 0.73 ± 0.33 | < 0.001* |
| Number of patients per hour (n) | 60,838 ± 21,159 | 74,929 ± 6495 | 50,773 ± 22,384 | 0.002* |
| Ratio of patients per hour (%) | 4.67 ± 1.26 | 5.24 ± 0.59 | 3.89 ± 1.49 | < 0.001* |
| Clinical outcomes [ | ||||
| 28-day mortality | 421 (21.71) | 240 (21.33) | 181 (22.24) | 0.634 |
| In-hospital mortality | 444 (21.67) | 252 (21.36) | 192 (22.09) | 0.688 |
| ICU admission | 758 (36.99) | 436 (36.95) | 322 (37.05) | 0.961 |
| Adherence to SSC bundle [ | ||||
| Full SSC bundle | 630 (30.75) | 330 (27.97) | 300 (34.52) | 0.002* |
| Antibiotic administration | 1356 (66.31) | 751 (63.64) | 605 (69.94) | 0.003* |
| Lactate measurement | 1755 (86.67) | 1000 (85.91) | 755 (87.69) | 0.245 |
| Blood culture drawn | 1370 (67.22) | 781 (66.47) | 589 (68.25) | 0.397 |
| Fluid administration | 1482 (72.33) | 837 (70.93) | 645 (74.22) | 0.099 |
| Administration of vasopressors | 967 (53.63) | 551 (53.03) | 416 (54.45) | 0.551 |
SSC Surviving Sepsis Campaign, SOFA Sequential Organ Failure Assessment, APACHE Acute Physiologic Assessment and Chronic Health Evaluation, AIDS acquired immunodeficiency syndrome, GI gastrointestinal, ICU intensive care unit
*p < 0.05
Fig. 2The patient to doctor ratio according to time zone in emergency department and the compliance rate for the complete Surviving Sepsis Campaign 3-h bundle. The bars indicate the patient to doctor ratio. The compliance rate for the complete sepsis bundle is shown by the dashed line, and the average 28-day mortality rate in the daytime and nighttime is represented by the solid line
The hospital stratified multivariable logistic regression analysis to identify variables significantly and independently associated with the SSC treatment bundle
| Variable | Complete SSC bundle | |
|---|---|---|
| AOR (95% CI) | ||
| Age (per 1 years) | 1.001 (0.993–1.009) | 0.823 |
| Male (vs female) | 1.0013 (0.816–1.229) | 0.990 |
| APACHE II score (per 1point) | 1.0107 (0.998–1.024) | 0.113 |
| Lactate (per 1 mmol/L) | 1.0122 (0.979–1.047) | 0.475 |
| C-reactive protein (mg/L) | 0.999 (0.991–1.007) | 0.803 |
| Patient/doctor ratio | 0.999 (0.999–1.000) | 0.289 |
| Arrival time | ||
| Daytime | Reference | |
| Nighttime | 1.368 (1.115–1.678) | 0.003* |
SSC Surviving Sepsis Campaign, AOR adjusted odds ratio, 95% CI 95% confidence interval, APACHE Acute Physiologic Assessment and Chronic Health Evaluation
*P < 0.05
Adjusted odds ratio from stratified multivariable logistic regression between emergency department arrival during nighttime hours and compliance with individual components of the SSC treatment bundle
| Compliance with | AORa (95% CI) | |
|---|---|---|
| Night admission (vs day admission) | ||
| Timely antibiotic administration | 1.326 (1.088–1.617) | 0.005* |
| Timely lactate measurement | 1.145 (0.867–1.514) | 0.340 |
| Timely blood cultures | 1.012 (0.787–1.302) | 0.925 |
| Timely fluid administration | 1.125 (0.918–1.296) | 0.147 |
| Timely administration of vasopressors | 1.137 (0.929–1.392) | 0.214 |
SSC Surviving Sepsis Campaign, OR odds ratio, 95% CI 95% confidence interval
aAdjusted for: age, sex, APACHE II score, lactate, C-reactive protein level, patients/doctor ratio
*P < 0.05
The hospital stratified multivariate Cox proportional-hazards regression analysis to identify variables significantly and independently associated with 28-day mortality (A) and hospital mortality rates (B)
| Variable | 28-day mortality | |||
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Age | 1.004 (0.996–1.012) | 0.344 | 1.003 (0.995–1.011) | 0.412 |
| Male sex | 1.030 (0.835–1.271) | 0.781 | 1.037 (0.840–1.279) | 0.737 |
| APACHE II score | 1.088 (1.075–1.101) | < 0.001* | 1.087 (1.074–1.100) | < 0.001* |
| Lactate | 1.105 (1.078–1.132) | < 0.001* | 1.103 (1.076–1.130) | < 0.001* |
| C-reactive protein | 1.004 (0.996–1.012) | 0.357 | 1.004 (0.996–1.012) | 0.351 |
| Patients/doctor ratio | 0.999 (0.999–1.000) | 0.679 | 0.100 (0.999–1.000) | 0.759 |
| Source of infection | ||||
| Hepato-biliary and pancreas | 0.793 (0.567–1.110) | 0.177 | 0.785 (0.561–1.098) | 0.157 |
| Mixed source | 1.146 (0.838–1.566) | 0.394 | 1.139 (0.834–1.556) | 0.413 |
| Respiratory tract | 1.288 (0.995–1.668) | 0.055 | 1.236 (0.956–1.597) | 0.106 |
| Urinary tract | 0.454 (0.309–0.667) | < 0.001* | 0.453 (0.308–0.664) | < 0.001* |
| Timely antibiotic administration | 0.742 (0.600–0.916) | 0.006* | ||
| Adherence of complete SSC bundle | 0.750 (0.590–0.952) | 0.018* | ||
HR hazard ratio, 95% CI 95% confidence interval, APACHE Acute Physiologic Assessment and Chronic Health Evaluation, SSC Surviving Sepsis Campaign
*P < 0.05
Fig. 3Relationships between the adherence to the SSC 3-h bundle, 28-day mortality (A) and in-hospital mortality (B). The completion of SSC 3-h bundle was significantly associated with a decreased 28-day and in-hospital mortality risk among patients with septic shock. HR hazard ratio, 95% CI 95% confidence interval, SSC Surviving Sepsis Campaign